Molecular Technologies Laboratories LLC

États‑Unis d’Amérique

 
Quantité totale PI 9
Rang # Quantité totale PI 171 606
Note d'activité PI 1,7/5.0    8
Rang # Activité PI 114 929
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

3 1
3 0
2 0
0
 
Dernier brevet 2024 - Growth hormone antagonist and an...
Premier brevet 2018 - Pegylated growth hormone antagon...
Dernière marque 2022 - RAPID INNOVATE MODEL
Première marque 2022 - RAPID INNOVATE MODEL

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Growth hormone antagonist and anti-cancer composition combination therapy. A composition for tre...
2022 P/S Development of new technology for others in the field of Biotechnology, namely, drug discovery se...
Invention Growth hormone antagonist and anti-cancer composition combination therapy. A composition for trea...
2021 Invention Apparatus and system for cooling. A cooling apparatus includes thermosyphon loops for cooling mu...
2020 Invention Therapeutic pegylated growth hormone antagonists. A growth hormone receptor antagonist, comprisin...
2019 Invention Pegylated growth hormone antagonists. A composition that is a human growth hormone receptor antag...